6680

Uridine

• Synonym(s): Uridine
• Empirical Formula (Hill Notation): C₉H₁₂N₂O₆
• CAS Number: 58-96-8
• Molecular Weight: 244.20
• UNSPSC Code: 12352208
• NACRES: NA.51
• MDL number: MFCD00006526
• Assay: ≥97% (HPLC)
• Form: solid
• Solubility: water: soluble
• Storage temp.: 15-25°C

Properties

• description: RTECS - YR1450000; Merck USA index - 14, 9877
• Quality Segment: 100
• assay: ≥97% (HPLC)
• form: solid
• manufacturer/tradename: Calbiochem^®
• storage condition: OK to freeze
• impurities: ≤1% ash
• color: white to off-white
• solubility: water: soluble
• cation traces: heavy metals: <10 ppm
• shipped in: ambient
• storage temp.: 15-25°C
• SMILES string: [nH]1[c]([n](cc[c]1=O)C2OC(C(C2O)O)CO)=O
• InChI: 1S/C9H12N2O6/c12-3-4-6(14)7(15)8(17-4)11-2-1-5(13)10-9(11)16/h1-2,4,6-8,12,14-15H,3H2,(H,10,13,16)
• InChI key: DRTQHJPVMGBUCF-UHFFFAOYSA-N

Description

Application

• Modified Nucleotides and RNA Structure Prediction.: This research explores the impact of modified nucleotides, including uridine analogs, on RNA structure prediction. The study advances our understanding of RNA biology and the role of uridine modifications in gene expression and regulation, highlighting the importance of uridine in biochemical research (Varenyk and Lorenz, 2024).


• CAD-Related Disorder (EIEE-50) in an Infant With Cortical Visual Impairment.: This article discusses the application of uridine in the context of CAD-related disorders. The study suggests that uridine supplementation may have therapeutic benefits for infants with cortical visual impairment and related metabolic disorders (Thurman et al., 2024).

Preparation Note

Following reconstitution, aliquot and freeze (-20°C).

Legal Information

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

Toxicity: Standard Handling (A)

Safety Information

• Storage Class: 11 - Combustible Solids
• WGK: WGK 3
• Flash Point (°F): Not applicable
• Flash Point (°C): Not applicable